v3.24.3
Consolidated Statements Of Cash Flows
$ in Thousands
 12 Months Ended
Sep. 27, 2024
USD ($)
Sep. 29, 2023
USD ($)
Sep. 30, 2022
USD ($)
Operating activities:      
Net income including controlling interest $ 264,316 $ 201,644 $ 183,898
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 75,559 82,558 88,461
Stock-based compensation 119,825 118,486 114,925
Amortization of operating lease right-of-use assets 11,768 12,956 15,148
Amortization of premium on investments (2,919) (860) 1,440
Provision for doubtful accounts (2,256) (793) 5,460
Deferred income taxes (21,612) (18,337) (29,465)
Impairment loss on internally developed software 0 16,225 0
Other non-cash items affecting net income (10,828) (2,800) (5,037)
Changes in operating assets and liabilities:      
Accounts receivable (28,967) 47,779 (14,314)
Contract assets, net (8,707) 347 6,300
Inventories (2,654) (13,226) (11,759)
Operating lease right-of-use assets (8,420) (8,817) 266
Prepaid expenses and other assets 10,097 3,868 8,760
Accounts payable and other liabilities (34,554) (52,315) (33,542)
Income taxes, net (4,501) (8,722) 8,446
Contract liabilities (9,738) (8,379) (413)
Operating lease liabilities (5,263) (5,818) (15,399)
Other non-current liabilities (13,894) 3,285 (4,599)
Net cash provided by operating activities 327,252 367,081 318,576
Investing activities:      
Purchases of marketable securities (160,198) (172,955) (311,313)
Proceeds from sales of marketable securities 234,061 54,964 9,459
Proceeds from maturities of available-for-sale securities 157,729 176,833 108,546
Purchases of property, plant and equipment (30,007) (30,339) (47,928)
Acquisitions, net of cash acquired (487,877) 25,703 (38,171)
Purchases of intangible assets 0 0 (11,528)
Purchases of other investments 0 0 (5,000)
Net cash provided by/(used in) investing activities (286,292) 54,206 (295,935)
Financing activities:      
Proceeds from issuance of common stock 40,203 47,781 57,848
Repurchase of common stock (160,001) (149,276) (530,486)
Payment of cash dividend (114,579) (103,407) (100,067)
Distribution to controlling interest (5,164) (266) (1,435)
Purchase of noncontrolling interest in business combinations (9,920) 0 0
Equity issued in connection with business combination 722 0 0
Shares repurchased for tax withholdings on vesting of restricted stock (39,075) (31,144) (36,418)
Payments for Deferred Consideration 0 500 0
Net cash used in financing activities (287,814) (236,812) (610,558)
Effect of foreign exchange rate changes on cash and cash equivalents 6,640 5,120 (16,744)
Net increase/(decrease) in cash, cash equivalents, and restricted cash (240,214) 189,595 (604,661)
Cash, cash equivalents, and restricted cash at beginning of period 817,966 628,371 1,233,032
Cash, cash equivalents, and restricted cash at end of period 577,752 817,966 628,371
Supplemental disclosure:      
Cash paid for income taxes, net of refunds received 63,217 61,481 40,340
Non-cash investing activities:      
Change in property, plant, and equipment purchased, unpaid at period-end 8,711 3,882 (1,481)
Accrual of unpaid stock repurchase excise tax 261 0 0
Equity issued in connection with business combination $ 0 $ 21,198 $ 0